Both in Diagnostics
Achieve Life Sciences vs Insight Molecular Diagnostics
Over the past year ACHV returned +45.1% and IMDX returned −56.8%; their daily moves had a correlation of 0.16.
ACHV +45.1% IMDX −56.8%Growth of $1, one year, split-adjusted
| Metric | ACHV | IMDX |
|---|---|---|
| Price | $6.98 | $2.65 |
| Market cap | $719.7M | $86.7M |
| Today | +3.71% | −3.28% |
| 1 month | −0.7% | −21.6% |
| 6 months | +45.4% | −47.3% |
| Year to date | +40.4% | −64.7% |
| 1 year | +36.6% | −56.7% |
| Revenue growth (YoY) | — | −53.9% |
| Gross margin | — | 65.7% |
| Net margin | — | −4711.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 51.9× |
| Net cash | $172.4M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 94.8% |
| Short % of float | 28.1% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).